Mutant JAK3 kinase in human leukemia

Details for Australian Patent Application No. 2007207516 (hide)

Owner Cell Signaling Technology, Inc.

Inventors Druker, Brian; Walters, Denise; Polakiewicz, Roberto; Goss, Valerie; Gu, Ting-lei

Agent Griffith Hack

Pub. Number AU-A-2007207516

PCT Pub. Number WO2007/084630

Priority 60/760,673 20.01.06 US

Filing date 19 January 2007

Wipo publication date 26 July 2007

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12N 15/64 (2006.01) Mutation or genetic engineering - General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

11 September 2008 PCT application entered the National Phase

  PCT publication WO2007/084630 Priority application(s): WO2007/084630

26 November 2009 Assignment before Grant

  Cell Signaling Technology, Inc. The application has been assigned to Oregon Health and Science University

10 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007207519-Viable non-toxic gram negative bacteria

2007207513-System and method for improving the accommodative amplitude and increasing the refractive power of the human lens with a laser